View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Uncategorised
December 1, 2021

Coronavirus company news summary – DiaCarta develops Covid-19 test to detect new variant – Rheonix confirms its Covid-19 test detects Omicron Variant

By Kezia Parkins

US-based molecular diagnostics company DiaCarta has developed a new test to detect the new emerging Covid-19 variant, Omicron. The new multiplex qPCR-based test named QuantiVirus SARS-CoV-2 Variant Detection is based on DiaCarta’s proprietary XNA technology. It is designed to identify the SARS-CoV-2 virus and then distinguish various mutating variants. The company has secured CE/IVD marking and will commercialise this test globally.

Rheonix has confirmed that its Covid-19 MDx Assay is capable of detecting the emerging Omicron variant. The company said that the RT-PCR assay can also identify other SARS-CoV-2 variants of concern. The Rheonix Covid-19 MDx Assay is designed for the qualitative detection of nucleic acid from SARS-CoV-2 using saliva samples. The test is yet to be approved by the US Food and Drug Administration (FDA). However, the FDA has granted the test emergency use authorization (EUA) for use by authorised laboratories. 

Health technology company Detect has said that its PCR-quality, at-home rapid Covid-19 Test recognises the Covid-19 Omicron variant. The company made the announcement following a comprehensive bioinformatics analysis. The test is said to offer results in less than one hour. Recently, Detect’s Covid-19 Test was selected for the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics Initiative (RADxSM) to increase production.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Medical Device Network